Brentuximab vedotin and dose attenuated chemoimmunotherapy for patients 75 years and older with diffuse large B-cell lymphoma with analysis of outcomes by frailty
Fields of Study & Subjects
Lymphoma Diagnosis and Treatment
Cutaneous lymphoproliferative disorders research
CAR-T cell therapy research
Publication details
- Journal / source
- Journal of Geriatric Oncology
- Publisher
- Elsevier BV
- Volume
- 17
- Issue
- 3
- Pages
- 102932–102932
- Publication date
- 5 March 2026
- Language
- EN